Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery

References

• Marije VD, Bannink EMN, Pareren YK, et al. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls. J Clin Endocrinol Metab 2007;92:160–5.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Nikhil M, Reagan JL, et al. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood 2012;119:4845–50.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50.
   PubMed Web of Science ®Google Scholar
• Daivadanam M, Absetz P, Sathish T, et al. Lifestyle change in Kerala, India: needs assessment and planning for a community-based diabetes prevention trial. BMC Public Health 2013;13:72–85.
   PubMed Web of Science ®Google Scholar
• Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Endocrinologist 1999;9:2005.
   Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713–19.
   PubMed Web of Science ®Google Scholar
• Guillausseau PJ. Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus. Treat Endocrinol 2005;4:167–75.
   PubMedGoogle Scholar
• van Galen KA, Nellen JF, Nieuwkerk PT. The effect on treatment adherence of administering drugs as fixed-dose combinations versus as separate pills: systematic review and meta-analysis. Aids Res Treat 2014;2014:967073.
   PubMedGoogle Scholar
• Goldstein BJ, Pans M, Rubin CJ. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea. Clin Ther 2003;25:890–903.
   PubMed Web of Science ®Google Scholar
• Marre M, Howlett H, Lehert P, et al. Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in type 2 diabetic patients inadequately controlled on metformin. Diabet Med 2002;19:673–80.
   PubMed Web of Science ®Google Scholar
• Bakker A, Paes AH, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512–17.
   PubMed Web of Science ®Google Scholar
• Conley R, Gupta SK, Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS*), an advanced oral delivery form. Curr Med Res Opin 2006;22:1879–92.
   PubMed Web of Science ®Google Scholar
• Feinglos M, Dailey G, Cefalu W, et al. Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM. Diabetes Res Clin Pract 2005;68:167–75.
   PubMed Web of Science ®Google Scholar
• Gupta BP, Thakur N, Jain NP, et al. Osmotically controlled drug delivery system with associated drugs. J Pharm Pharm Sci 2010;13:571–88.
   PubMed Web of Science ®Google Scholar
• Chen J, Pan H, Ye T, et al. Recent aspect of osmotic pump system: functionalization, clinical use and advanced imaging technology. Curr Drug Metabolism 2015;75:183–6.
   Google Scholar
• Malaterre V, Ogorka J, Loggia N, et al. Oral osmotically driven systems: 30 years of development and clinical use. Eur J Pharm Biopharm 2009;73:311–23.
   PubMed Web of Science ®Google Scholar
• Wei L, Li J, Guo L, et al. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm 2007;33:990–8.
   PubMed Web of Science ®Google Scholar
• Xi Z, Yi Y, Qi J, et al. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: Near zero-order release and pharmacokinetics in dogs. Int J Pharm 2013;452:233–40.
   PubMed Web of Science ®Google Scholar
• Liu D, Yu S, Zhu Z, et al. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: In vitro and in vivo evaluation. Int J Pharm 2014;475:496–503.
   PubMed Web of Science ®Google Scholar
• Yang XG, Peng B, Zhang GH, et al. Studies of the pharmacokinetics of paeoniflorin in two Jing-Zhi-Guan-Xin formulations after oral administration to beagle dogs. J Pharm Biomed Anal 2006;41:320–4.
   PubMed Web of Science ®Google Scholar
• Qin C, He W, Zhu C, et al. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm 2014;466:276–85.
   PubMed Web of Science ®Google Scholar
• Patel G, Asodaria K, Patel H, et al. Development of controlled release osmotic pump tablet of glipizide solid dispersion. Curr Drug Deliv 2013;817–27.
   Web of Science ®Google Scholar
• Prabakaran D, Singh P, Kanaujia P, et al. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm 2004;284:95–108.
   PubMed Web of Science ®Google Scholar
• Defang O, Shufang N, Wei L, et al. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets. J Pharm Pharmacol 2005;57:817–20.
   PubMed Web of Science ®Google Scholar
• Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release 2002;79:7–27.
   PubMed Web of Science ®Google Scholar
• Balachandran M, Devanathan S. Optimizing properties of nanoclay–nitrile rubber (NBR) composites using face centred central composite design. Mater Design 2012;35:854–62.
   Web of Science ®Google Scholar
• Nekkanti V, Marwah A, Pillai R. Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE). Drug Dev Ind Pharm 2015;41:124–30.
   PubMed Web of Science ®Google Scholar
• Defang O, Shufang N, Wei L, et al. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm 2008;31:677–85.
   Web of Science ®Google Scholar
• Sujana K, Rani GS, Prasad MB, et al. Simultaneous estimation of pioglitazone hydrochloride and metformin hydrochloride using UV spectroscopic method. J Biomed Sci Res 2010;2:110–15.
   Google Scholar
• Dubey A, Shukla IC. Simultaneous determination of Glipizide and Metformin hydrochloride in pharmaceutical preparation by HPLC. J Indian Chem Soc 2004;81:84–6.
   Web of Science ®Google Scholar
• Shah VP, Yi T, Sathe P, et al. In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f2. Pharm Res 1998;15:889–96.
   PubMed Web of Science ®Google Scholar
• Sathe PM, Yi T, Shah VP. In-vitro dissolution profile comparison: Statistics and analysis, model dependent approach. Pharm Res 1997;13:1799–803.
   Web of Science ®Google Scholar
• Dudhipala N, Veerabrahma K. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Drug Dev Ind Pharm 2015;41:10–11.
   Web of Science ®Google Scholar
• Madhukar A, Prince A, Kumar RV, et al. Simple and sensitive analytical method development and validation of metformin hydrochloride by RP-HPLC. Int J Pharm Pharm Sci 2011;3:117–20.
   Google Scholar
• Bae J, Kim N, Choi C, et al. HPLC analysis of plasma glipizide and its application to pharmacokinetic study. J Liq Chrom Relat Tech 2009;13:1969–77.
   Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, et al. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm 2008;68:289–97.
   PubMed Web of Science ®Google Scholar
• Yong G. Progress in study on delivery system of osmotically release-controlled and poorly water-soluble drugs [PhD Thesis]. Shenyang: Shenyang Pharmaceutical University; 2002.
   Google Scholar
• Mutahar RKM, Dinesh BM, Kumar V. A novel expandable core of elementary osmotic pump:an effective device for delivery of poorly water-soluble drugs. Int Res J Pharm 2011;2:178–84.
   Google Scholar
• He W, Yang M, Fan JH, et al. Influences of sodium carbonate on physicochemical properties of lansoprazole in designed multiple coating pellets. AAPS PharmSciTech 2010;11:1287–93.
   PubMed Web of Science ®Google Scholar
• Badawy SIF, Hussain MA. Microenvironmental pH modulation in solid dosage forms. J Pharm Sci 2007;96:948–59.
   PubMed Web of Science ®Google Scholar
• Chika T, Yohei K, Koichi W, et al. Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility. Exp Opin Drug Deliv 2014;11:505–16.
   PubMed Web of Science ®Google Scholar
• Dubernet C, Benoit JP, Peppas NA, et al. Ibuprofen-loaded ethylcellulose microspheres: release studies and analysis of the matrix structure through the Higuchi model. J Microencapsul 2008;7:555–65.
   Web of Science ®Google Scholar
• Saravanan M, Bhaskar K, Srinivasa RG, et al. Ibuprofen-loaded ethylcellulose/polystyrene microspheres: an approach to get prolonged drug release with reduced burst effect and low ethylcellulose content. J Microencapsul 2003;20:289–302.
   PubMed Web of Science ®Google Scholar
• Thakare M, Israel B, Garner ST, et al. Formulation parameters and release mechanism of theophylline loaded ethyl cellulose microspheres: effect of different dual surfactant ratios. Pharm Dev Technol 2013;18:1213–19.
   PubMed Web of Science ®Google Scholar
• Narasimhan B, Langer R. Zero-order release of micro- and macromolecules from polymeric devices: the role of the burst effect. J Control Release 1997;47:13–20.
   Web of Science ®Google Scholar